Effect of Kinesio Tape on Oral and Pharangeal Swallowing Phases in Children With Spastic Cerebral Palsy

NCT ID: NCT06157489

Last Updated: 2023-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of current study is to investigate the effect of kinesio tape in children with spastic cerebral palsy having oropharyngeal dysphagia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study tageted rhe children with spastic cerebral palsy from both sexes will be selected from hospital of Tanta university

Inclusion criteria:

1. Age ranges from 2 to 7 years.
2. The degree of dysphagia ranges from 4 to 6 level according to functional oral intake scale (appendix II).
3. Diagnosed as spastic diplegia or quadriplegia.
4. Able to understand and follow instructions.

Exclusion criteria:

Children will be excluded if they have any of the following criteria:

1. Severe visual and auditory problems.
2. History of maxillary, head or neck surgical procedures.
3. Botulinum toxin treatment of upper esophageal sphincter dysfunction, esophageal dysphagia and/or gastroesophageal reflux disease during the previous six months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dysphagia, Oropharyngeal, Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Active Comparator: Kinesiotape Group In active group, KT was applied in masseter muscle, orbicularis oris and infrahyoid muscles for facilitating suprahyoid muscle and oral sensorimotor exercise In sham group will receive the oral sensorimotor exercise only
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hamza

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Noor mohamed

Group Type SHAM_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Janna ahmed

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Hamza salah

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Mohammed asel

Group Type SHAM_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Ali ahmed

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Malek Mohamed

Group Type SHAM_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Sayed Mohamed

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Omar ahmed

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Ahmed Mohamed

Group Type SHAM_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Yousef salah

Group Type SHAM_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Rofan ahmed

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Kinesio tape hasnot assigned to arm group Exercise only

Group Type SHAM_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Fareda salah

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Abd elrahman ahmed

Group Type ACTIVE_COMPARATOR

Kinesio tape

Intervention Type OTHER

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesio tape

Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ranges from 3 to 7 years.
2. The degree of dysphagia ranges from 4 to 6 level according to functional oral intake scale (appendix II).
3. Diagnosed as spastic diplegia or quadriplegia.
4. Able to understand and follow instructions.

Exclusion Criteria

Children will be excluded if they have any of the following criteria:

1. Severe visual and auditory problems.
2. History of maxillary, head or neck surgical procedures.
3. Botulinum toxin treatment of upper esophageal sphincter dysfunction, esophageal dysphagia and/or gastroesophageal reflux disease during the previous six months.
Minimum Eligible Age

2 Years

Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hadeer Samy Abd Elaziz Alawy

Demonstrator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hadeer samy abd elaziz

Tanta, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hadeer Samy Abd elaziz

Role: CONTACT

Phone: 01097917913

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hadeer Samy Abd elaziz

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

004448

Identifier Type: -

Identifier Source: org_study_id